86 related articles for article (PubMed ID: 9857085)
1. Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists.
Madsen P; Knudsen LB; Wiberg FC; Carr RD
J Med Chem; 1998 Dec; 41(26):5150-7. PubMed ID: 9857085
[TBL] [Abstract][Full Text] [Related]
2. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent, orally active benzimidazole glucagon receptor antagonists.
Kim RM; Chang J; Lins AR; Brady E; Candelore MR; Dallas-Yang Q; Ding V; Dragovic J; Iliff S; Jiang G; Mock S; Qureshi S; Saperstein R; Szalkowski D; Tamvakopoulos C; Tota L; Wright M; Yang X; Tata JR; Chapman K; Zhang BB; Parmee ER
Bioorg Med Chem Lett; 2008 Jul; 18(13):3701-5. PubMed ID: 18539028
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
Giardina GA; Raveglia LF; Grugni M; Sarau HM; Farina C; Medhurst AD; Graziani D; Schmidt DB; Rigolio R; Luttmann M; Cavagnera S; Foley JJ; Vecchietti V; Hay DW
J Med Chem; 1999 Mar; 42(6):1053-65. PubMed ID: 10090788
[TBL] [Abstract][Full Text] [Related]
5. Benzimidazoles as non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 3: Discovery of 1-(1H-benzimidazol-5-yl)-3-tert-butylurea derivatives.
Tatsuta M; Kataoka M; Yasoshima K; Sakakibara S; Shogase Y; Shimazaki M; Yura T; Li Y; Yamamoto N; Gupta J; Urbahns K
Bioorg Med Chem Lett; 2005 May; 15(9):2265-9. PubMed ID: 15837306
[TBL] [Abstract][Full Text] [Related]
6. Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor.
Duffy JL; Kirk BA; Konteatis Z; Campbell EL; Liang R; Brady EJ; Candelore MR; Ding VD; Jiang G; Liu F; Qureshi SA; Saperstein R; Szalkowski D; Tong S; Tota LM; Xie D; Yang X; Zafian P; Zheng S; Chapman KT; Zhang BB; Tata JR
Bioorg Med Chem Lett; 2005 Mar; 15(5):1401-5. PubMed ID: 15713396
[TBL] [Abstract][Full Text] [Related]
7. New beta-alanine derivatives are orally available glucagon receptor antagonists.
Lau J; Behrens C; Sidelmann UG; Knudsen LB; Lundt B; Sams C; Ynddal L; Brand CL; Pridal L; Ling A; Kiel D; Plewe M; Shi S; Madsen P
J Med Chem; 2007 Jan; 50(1):113-28. PubMed ID: 17201415
[TBL] [Abstract][Full Text] [Related]
8. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
Shen DM; Zhang F; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Dragovic J; Feeney WP; Jiang G; McCann PE; Mock S; Qureshi SA; Saperstein R; Shen X; Tamvakopoulos C; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2005 Oct; 15(20):4564-9. PubMed ID: 16102966
[TBL] [Abstract][Full Text] [Related]
10. Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks.
Sawada Y; Kayakiri H; Abe Y; Mizutani T; Inamura N; Asano M; Hatori C; Aramori I; Oku T; Tanaka H
J Med Chem; 2004 May; 47(11):2853-63. PubMed ID: 15139763
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
[TBL] [Abstract][Full Text] [Related]
12. Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties.
Madsen P; Kodra JT; Behrens C; Nishimura E; Jeppesen CB; Pridal L; Andersen B; Knudsen LB; Valcarce-Aspegren C; Guldbrandt M; Christensen IT; Jørgensen AS; Ynddal L; Brand CL; Bagger MA; Lau J
J Med Chem; 2009 May; 52(9):2989-3000. PubMed ID: 19385613
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series.
Rivara M; Zuliani V; Cocconcelli G; Morini G; Comini M; Rivara S; Mor M; Bordi F; Barocelli E; Ballabeni V; Bertoni S; Plazzi PV
Bioorg Med Chem; 2006 Mar; 14(5):1413-24. PubMed ID: 16263297
[TBL] [Abstract][Full Text] [Related]
14. Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3.
Hayes ME; Wallace GA; Grongsaard P; Bischoff A; George DM; Miao W; McPherson MJ; Stoffel RH; Green DW; Roth GP
Bioorg Med Chem Lett; 2008 Mar; 18(5):1573-6. PubMed ID: 18242988
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
[TBL] [Abstract][Full Text] [Related]
17. Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands.
Aslanian R; Zhu X; Vaccaro HA; Shih NY; Piwinski JJ; Williams SM; West RE
Bioorg Med Chem Lett; 2008 Sep; 18(18):5032-6. PubMed ID: 18752952
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Ishikawa M; Moriya M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):4997-5001. PubMed ID: 18752943
[TBL] [Abstract][Full Text] [Related]
19. Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists.
McDonald IM; Austin C; Buck IM; Dunstone DJ; Gaffen J; Griffin E; Harper EA; Hull RA; Kalindjian SB; Linney ID; Low CM; Patel D; Pether MJ; Raynor M; Roberts SP; Shaxted ME; Spencer J; Steel KI; Sykes DA; Wright PT; Xun W
J Med Chem; 2007 Oct; 50(20):4789-92. PubMed ID: 17850061
[TBL] [Abstract][Full Text] [Related]
20. Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists.
Dallas-Yang Q; Shen X; Strowski M; Brady E; Saperstein R; Gibson RE; Szalkowski D; Qureshi SA; Candelore MR; Fenyk-Melody JE; Parmee ER; Zhang BB; Jiang G
Eur J Pharmacol; 2004 Oct; 501(1-3):225-34. PubMed ID: 15464082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]